3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform
DE · EN Newsletter
Biotech & Pharma Symbolbild · KI-generiert
Biotech & Pharma KIDS

OrthoPediatrics Corp.

KIDS NASDAQ Biotech & Pharma

Stock factsheet

TickerKIDS
ExchangeNASDAQ
ISIN
WKN
SectorBiotech & Pharma
Size class Small Cap
Market capitalisation 519 Mio. USD As of 2026-08-03

Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.

Company profile

OrthoPediatrics develops and markets orthopaedic implants and instruments designed specifically for the treatment of bone and joint conditions in children. Its product portfolio includes implants for the spine, extremities and trauma, tailored to the anatomical characteristics of paediatric patients. The company serves orthopaedic surgeons worldwide.

Short profile generated automatically and checked for plausibility. A full editorial profile follows once we cover the company.

Share price

Price data from TradingView, possibly delayed. Not investment advice.

Comparable companies

Companies in the Biotech & Pharma sector of a similar size.

CompanyTickerExchangeMarket cap
OrthoPediatrics Corp.KIDS NASDAQ519 Mio. USD
Arvinas, Inc. ARVNNASDAQ 518 Mio. USD
Crescent Biopharma, Inc. CBIONASDAQ 516 Mio. USD
Zura Bio Limited ZURANASDAQ 516 Mio. USD
Prime Medicine, Inc. PRMENASDAQ 527 Mio. USD
Verastem, Inc. VSTMNASDAQ 510 Mio. USD
ARS Pharmaceuticals, Inc. SPRYNASDAQ 509 Mio. USD

Investor Relations

Annual reports Not recorded yet
Investor presentation Not recorded yet
Analyst coverage Not recorded yet

We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.

Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.